Brief: SynAct Pharma Affiliate TXP Pharma Gets Granted Patent In Canada
March 23 (Reuters) - SynAct Pharma AB SYNACT.ST :
* AFFILIATE, TXP PHARMA AG, WAS GRANTED A PATENT IN CANADA
RELATED
TO "ALPHA- AND GAMMA-MSH ANALOGUES"
Source text for Eikon: ID:nMFNHTLnG
Further company coverage: SYNACT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development